GFR Decline as an Alternative End Point to Kidney Failure in Clinical Trials: A Meta-analysis of Treatment Effects From 37 Randomized Trials
Lesley A. Inker(Tufts Medical Center), Andrew S. Levey(Tufts Medical Center), Hiddo J.L. Heerspink(University Medical Center Groningen), Hasi Mondal(Tufts University), Josef Coresh(New York University), Hocine Tighiouart(Tufts University), Tom Greene(University Medical Center Groningen), Christopher H. Schmid(Brown University), Farzad Noubary(General Department of Preventive Medicine)
Cited by 155
Related Papers
A New Equation to Estimate Glomerular Filtration Rate
|Annals of Internal Medicine|2009|25.7k
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
|Data Archiving and Networked Services (DANS)|2002|11.7k
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11.4k
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
|Annals of Internal Medicine|2015|8.2k
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k